Microba Life Sciences Limited (MAP.AX)
Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.
0.05+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-46.1%
The outlook
Microba Life Sciences Limited currently reads as neutral based on buy — 2.0 avg of 2 analysts, below its 50- & 200-day averages, 17% of the way from its 52-week low to high, avg target +75% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 2 analysts
Price trendBelow its 50- & 200-day averages
52-week range17% of the way from its 52-week low to high
Price targetAvg target +75% vs current price
Analyst price target
~12-month · 2 analysts0.08average target+75.2% vs now
Now 0.05
Low 0.05High 0.12
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$34.4M
52-wk high
0.11
52-wk low
0.04
50-day avg
0.05
200-day avg
0.07
Trailing P/E
—